US4480041A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Use of phosphotriester intermediates for preparation of functionalized liposomes
Assignee: Oscient Pharmaceuticals Corp
•
Filing: 1982-07-09
•
Granted: 1984-10-30
•
Expires: 2002-07-09
Abstract
Abstract A method of forming an analyte-functionalized liposome for use in immunoassay techniques employs a phosphotriester intermediate of a phospholipid derivatized with the desired analyte in a process of forming a liposome which is functionalized on its outer surface with the analyte and which carries an enzyme marker. The method is also used to functionalize the liposome with a ligand which acts as a leash between the analyte and the liposome. Liposomes produced by the method include penicillin-G-functionalized liposome.
Inventors
- 👤 Arthur Myles
- 👤 Say-Jong Law
- 👤 Frank X. Cole
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 07:46
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/585; G01N33/586; Y; Y10; Y10S; Y10S436/00; Y10S436/815; Y10S436/816; Y10S436/817; Y10S436/829
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
158 words
A method of forming an analyte-functionalized liposome for use in immunoassays comprising the steps of: a. obtaining an intermediate having the structure ##STR25## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR26## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR27## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the analyte desired to be attached, A is an analyte, and Y is a triester-blocking group; b. reacting said intermediate to form an amphiphilic compound having the structure ##STR28## c. forming a liposome from the product of step (b) which is functionalized on its surface with said analyte and has a marker carried within said liposome.
Claim 2
Independent Claim
158 words
A method of forming an analyte-functionalized liposome for use in immunoassays comprising the steps of: a. obtaining an intermediate having the structure ##STR25## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR26## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR27## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the analyte desired to be attached, A is an analyte, and Y is a triester-blocking group; b. reacting said intermediate to form an amphiphilic compound having the structure ##STR28## c. forming a liposome from the product of step (b) which is functionalized on its surface with said analyte and has a marker carried within said liposome.
Claim 3
Independent Claim
135 words
A method of forming a ligand-functionalized liposome for subsequent attachment of an analyte to the ligand functional group to provide a compound for use in immunoassays wherein said ligand-functionalized liposome is derived from an intermediate having the structure ##STR29## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR30## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), and wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR31## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the ligand desired to be attached, Y is a triester-blocking group, and L is a ligand.
Claim 4
Independent Claim
135 words
A method of forming a ligand-functionalized liposome for subsequent attachment of an analyte to the ligand functional group to provide a compound for use in immunoassays wherein said ligand-functionalized liposome is derived from an intermediate having the structure ##STR29## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR30## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), and wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR31## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the ligand desired to be attached, Y is a triester-blocking group, and L is a ligand.
Claim 5
Dependent Claim
50 words
The method of claim 2, further comprising the steps of: a. reacting said intermediate to form a compound having the structure ##STR32## b. forming a liposome from the product of step (a) which is functionalized on its surface with said ligand and which has a marker carrier within said liposome.
Claim 6
Dependent Claim
24 words
The method of claim 3, further comprising reacting the product thus obtained to attach an analyte to the ligand functional group of the liposome.
Claim 7
Dependent Claim
74 words
The method of claim 2, further comprising the steps of: a. reacting said intermediate to form a compound having the structure ##STR33## where A is an analyte; b. reacting the product of step (a) to form a compound having the structure ##STR34## c. forming a liposome from the product of step (b) which is functionalized on its surface with said ligand attached to said analyte and which has a marker carried within said liposome.
Claim 8
Independent Claim
199 words
A method of forming an analyte-functionalized liposome for use in immunoassays comprising the steps of: a. reacting an analyte with a ligand to form a compound of the formula L--A, where L is a ligand and A is an analyte; b. reacting the compound of step (a) with a phospholipid compound of the formula ##STR35## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR36## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), and wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR37## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the ligand desired to be attached, and Y is a triester-blocking group; to form an intermediate having the formula ##STR38## c. reacting said intermediate to form a compound having the structure ##STR39## d. forming a liposome from the product of step (c) which is functionalized on its surface with said ligand attached to said analyte and which has a marker carried within said liposome.
Claim 9
Independent Claim
199 words
A method of forming an analyte-functionalized liposome for use in immunoassays comprising the steps of: a. reacting an analyte with a ligand to form a compound of the formula L--A, where L is a ligand and A is an analyte; b. reacting the compound of step (a) with a phospholipid compound of the formula ##STR35## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR36## (where R" is selected from the group consisting of saturated, unsaturated, branched and straight-chain alkyl and alkylene groups of 1 to 24 carbons), and wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR37## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the ligand desired to be attached, and Y is a triester-blocking group; to form an intermediate having the formula ##STR38## c. reacting said intermediate to form a compound having the structure ##STR39## d. forming a liposome from the product of step (c) which is functionalized on its surface with said ligand attached to said analyte and which has a marker carried within said liposome.
Claim 10
Dependent Claim
63 words
The method of claim 1, claim 2 or claim 6, wherein said analyte is selected from a group of compounds and their derivatives which are capable of being coupled to the surface of liposomes, said group consisting of antigens, antibodies, circulating hormones, intracellular messengers, cyclic nucleotides, prostaglandins, therapeutic drugs, antibiotics, opiate drugs, ergot alkaloids, mycotoxins, natural toxicants, environmental food contaminants, and macromolecular antigens.
Claim 11
Dependent Claim
33 words
The method of claim 1, claim 2 or claim 6, wherein R 1 and R 2 are each of the formula ##STR40## and wherein R 3 is of the formula --CH.sub.2 --CH.sub.2 --NH--
Claim 12
Dependent Claim
13 words
A ligand-functionalized liposome prepared by the method of claim 2 or claim 3.
Claim 13
Dependent Claim
22 words
A ligand-functionalized liposome having an analyte attached to said ligand, prepared by the method of claim 4, claim 5 or claim 6.
Claim 14
Dependent Claim
155 words
In a method of forming an analyte-functionalized liposome for use in immunoassays wherein said liposome formed is functionalized on its surface with an analyte and has a marker carrier within said liposome, the improvement comprising the steps of: a. obtaining an intermediate having the structure ##STR41## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR42## (where R" is selected from the group consisting of saturated and unsaturated, branched straight-chain alkyl and alkylene groups of 1 to 24 carbons), wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR43## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the analyte desired to be attached, A is an analyte, and Y is a triester-blocking group; and b. reacting said intermediate to form an amphiphilic compound having the structure ##STR44##
Claim 15
Dependent Claim
155 words
In a method of forming an analyte-functionalized liposome for use in immunoassays wherein said liposome formed is functionalized on its surface with an analyte and has a marker carrier within said liposome, the improvement comprising the steps of: a. obtaining an intermediate having the structure ##STR41## where R 1 and R 2 are independently selected from the group consisting of H, OH, R", OR" and ##STR42## (where R" is selected from the group consisting of saturated and unsaturated, branched straight-chain alkyl and alkylene groups of 1 to 24 carbons), wherein at least one of R 1 and R 2 is selected from the group consisting of ##STR43## and OR"; and where R 3 is a side chain with a functional group capable of bonding to the analyte desired to be attached, A is an analyte, and Y is a triester-blocking group; and b. reacting said intermediate to form an amphiphilic compound having the structure ##STR44##
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-10-30 | 1988-04-30 | 1988-10-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-10-30 | 1992-04-30 | 1992-10-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-10-30 | 1996-04-30 | 1996-10-30 | $7700.00 | Window Closed / Lapsed |